Health · 19 views
GLP-1 diabetes drugs linked to up to 68% higher hair loss risk
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ finds.
Summary
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ finds.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Children with cancer are being saved, but are we breaking them in the process?Continue reading
- Sitting on Japanese tatami mats may reduce anxiety and support task engagementContinue reading
- ‘It’s Triage’: California’s Next Governor Will Face Destabilizing Surge in UninsuredContinue reading
- A breakthrough pancreatic cancer drug won approval. They still struggle to access itContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow